Severe COVID-19 in Children May Elevate Future Cardiovascular Risks

Recent research highlights that children who experience severe COVID-19 infections, including cases involving Multisystem Inflammatory Syndrome in Children (MIS-C), could face long-term cardiovascular health challenges. Scientists from Harvard University and Murdoch University’s Australian National Phenome Center analyzed blood samples from 147 children with varying COVID-19 conditions. Their findings revealed significant metabolic disturbances that persist beyond the initial infection phase, particularly affecting lipid processing pathways involving triglycerides and cholesterol—key elements in maintaining healthy heart and vessel function. While children are generally considered less prone to severe respiratory effects from COVID-19, this study demonstrates that the disease can cause notable cardiac damage, especially in those with MIS-C, which impacts multiple organ systems and leads to molecular changes associated with increased cardiovascular risk. The molecular signatures of MIS-C resemble those seen in COVID-19-infected children, with more severe metabolic disruption observed. Professor Jeremy Nicholson, lead researcher, emphasized that this challenges the assumption that children are largely safe from long-term effects of COVID-19, pointing to the importance of further research into potential lasting impacts on pediatric health. Given the global scale of over 750 million COVID-19 cases, understanding these long-term risks is urgent for public health planning and preventive strategies.